Q: What is your updated outlook on Pyrogenesis (PYR)? They appear to be getting closer to larger-scale production of a critical input for 'additive manufacturing' (3D printing) and the share price has started to move up.
Q: For a moderate risk investor, who tends towards long-term hold (with occasional portfolio adjustment), what would be a reasonable sector allocation? I have been a long-term member of 5iResearch and have learned a lot about investing. Thanks for the great service.
Q: Stock's up + nice profit ! Discussions for take out in progress. Appreciate your comments. Would you recommend to sell the stock or wait it out ? Thank you
Q: In reference to the Oaken Financial Savings account question:
An account can be open with Home Bank, Oaken financial, a joint account with Oaken, also a savings account for your spouse with Home Bank and Oaken Bank as well as a joint account with Home Bank. Thus $600,000 can be deposited at their high interest rate and be covered by CDIC
Stanley Cohen
Q: Based on bitter experience, I have concluded that preference shares are generally not suitable for an investor disinterested in gambling on interest rates.
My conclusion is based on the following:
- the only type of preference share which assures the investor of a fixed capital repayment amount is one subject to a mandatory fixed redemption date.
It seems to me (perhaps wrongly) that 1. reset shares will not necessarily trade for face value on the reset date and 2. floating rate shares would never necessarily trade at their face value
- in practice, the mandatory redemption type share is not available to a retail investor, if at all.
- apart from interest rate risk, I wonder whether there is a significant spread between bid and ask, placing the investor at an automatic disadvantage at the time of sale
Q: From your experience did you find that, in an upward market, inflow of money into mutual funds increases and therefore accelerates the upward momentum and the opposite is true as well? Today with all these ETFS can this occur with ETFS as well? Is the popularity of ETFS (funds flowing in and out) is adding to the volatility of the market. Would you see a panic scenario causing a major collapse?
Q: I'm doing research on RPI.UN and came across the is on the March 2, 2017 Press release:
"Net income was $7.9 million, or $0.73 per Unit, down $2.6 million from 2015 which mainly reflects higher EBITDA offset by contingent consideration for the Healthmark acquisition and the mark-to-market loss on exchangeable shares due to a $5.61/Unit appreciation."
What are the contigent considerations they are referring to?
Can you explain the mark-to-market loss on exchangeable shares?
Q: PNG is positioned in a rapidly growing market. How do you view PNG's long-term prospects in light of the recent funding by the NRC-IRAP and the private placement they announced today?
Q: I already have ENGH, KBL, TCN, AW.UN, CCL.B, CXI and HAC in my TFSA together with about 40% bonds. Can you suggest any of the Canadian stocks you cover which would be most suitable to add here? I guess for a TFSA capital appreciation is paramount.
Q: Is ZCL a company that you would be comfortable in going from a 3% position to full 5% position in. Total portfolio value of 140,000 split between TFSA's and RRSP's.
Thank You again
Q: I Have BEP.UN, and BPY.UN which have gone sideways for me in the last year, I also have BIP.UN which has done very well.
I am thinking of selling BEP and BPY and buying BAM.A with proceeds. Is this a good switch.
Thank You
Hooray for the ethical 5 I
My wife holds DH in her TFSA and her average purchase price was $28.08 per share (not ideal timing). It's only 0.38% of our overall portfolio. In the Technology sector, across all accounts, we own CSU (4.07%), ENGH (1.02%), KXS (0.68%), and OTEX (1.82%). What stock(s) in the same sector would you recommend to replace DH? I realize that our larger positions in CSU and OTEX probably eliminate further purchases, but would you say that adding to ENGH and KXS would be advisable? Or are there other Tech sector stocks we should consider? (We haven't yet decided to wait until DH is taken over and tender our shares, or to sell now if there are compelling reasons.)
Q: the alternative finance companies (non Bank lenders) share prices are under performing the markets for quite some time. I understand why HCG is struggling but is there a reason for most of the players in this space not doing well. Margin issues, access to capital, or possibly the improved climate for the USA banks. And if so what is the scenario for possible positive change